Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ligand Pharmaceuticals (LGNDZ) Shares Outstanding (Weighted Average) (2016 - 2025)

Ligand Pharmaceuticals (LGNDZ) has disclosed Shares Outstanding (Weighted Average) for 16 consecutive years, with $19.3 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) rose 5.73% to $19.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $19.3 million through Dec 2025, up 5.73% year-over-year, with the annual reading at $19.3 million for FY2025, 5.73% up from the prior year.
  • Shares Outstanding (Weighted Average) hit $19.3 million in Q4 2025 for Ligand Pharmaceuticals, roughly flat from $19.4 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $19.4 million in Q3 2025 to a low of $16.4 million in Q1 2021.
  • Historically, Shares Outstanding (Weighted Average) has averaged $17.6 million across 5 years, with a median of $17.3 million in 2023.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): dropped 0.57% in 2021 and later rose 8.23% in 2025.
  • Year by year, Shares Outstanding (Weighted Average) stood at $16.6 million in 2021, then grew by 1.43% to $16.9 million in 2022, then increased by 2.55% to $17.3 million in 2023, then rose by 5.73% to $18.3 million in 2024, then increased by 5.73% to $19.3 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for LGNDZ at $19.3 million in Q4 2025, $19.4 million in Q3 2025, and $19.3 million in Q2 2025.